ArticleACS medicinal chemistry letters2024

Potential Therapeutic Benefit of the Selective Inhibitors of Casitas B Cell Lymphoma-b (CBL-B) in Cancer Immunotherapy.

Ahmed F Abdel-MagidPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.